Literature DB >> 20952243

Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment?

Anne N Nisenzon1, Michael E Robinson, Dawn Bowers, Evangelia Banou, Irene Malaty, Michael S Okun.   

Abstract

BACKGROUND: Parkinson's disease (PD) impacts several domains of functioning, some of which may be neglected when designing treatment or evaluating outcome using current clinical standards. We therefore argue that taking the patients' perspectives of their condition may allow for a more in-depth assessment of patient goals and subsequent tailoring of care.
METHODS: One hundred and forty-eight patients with idiopathic PD completed a modified version of the Patient-Centered Outcomes Questionnaire (PCOQ-PD), to evaluate treatment success and expectations from the patient's perspective across 10 motor and non-motor functional domains. We also examined patient subgroups based on importance of improvement in various domains.
RESULTS: Patients' ratings suggested there was substantial variation in functional interference that was generally unrelated to demographic variables. On average, across all domains, patients indicated a 50.32% reduction in symptoms would be successful (range = 40.63-58.23%), regardless of treatment experience. Change scores between patients' usual levels of symptom interference and their treatment success levels suggested a greater degree of change was desired in motor versus non-motor domains (p < 0.05). Finally, cluster analyses revealed two patient subgroups based on overall importance of improvement (High vs. Low Importance Endorsement). Notably, the two groups differed in self-reported usual symptom levels despite having similar clinical severity.
CONCLUSIONS: We empirically examined treatment success from the PD patient's view as opposed to clinician judgment alone, thereby broadening the set of criteria by which to evaluate outcome. Findings from this exploratory study may guide future treatment emphases and guide patient-provider communication via clarification of patient-defined success.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20952243      PMCID: PMC3034811          DOI: 10.1016/j.parkreldis.2010.09.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  22 in total

1.  Treating neurodegenerative diseases.

Authors:  Leslie J Findley; Mary G Baker
Journal:  BMJ       Date:  2002-06-22

2.  Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.

Authors:  Rodrigo Mercado; Constantine Constantoyannis; Tomasz Mandat; Ajit Kumar; Michael Schulzer; A Jon Stoessl; Christopher R Honey
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

3.  Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.

Authors:  Katherine A Grosset; Donald G Grosset
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

4.  Reliability of measurements of patient health status: a comparison of physician, patient, and caregiver ratings.

Authors:  Cynthia McRae; Gretchen Diem; Alexander Vo; Christopher O'Brien; Lauren Seeberger
Journal:  Parkinsonism Relat Disord       Date:  2002-01       Impact factor: 4.891

Review 5.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease.

Authors:  M Faist; J Xie; D Kurz; W Berger; C Maurer; P Pollak; C H Lücking
Journal:  Brain       Date:  2001-08       Impact factor: 13.501

7.  Defining patient-centered, multidimensional success criteria for treatment of chronic spine pain.

Authors:  Jennifer L Brown; Penny S Edwards; James W Atchison; Ann Lafayette-Lucey; Virgil T Wittmer; Michael E Robinson
Journal:  Pain Med       Date:  2008-10       Impact factor: 3.750

8.  Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.

Authors:  J D O'Sullivan; C M Said; L C Dillon; M Hoffman; A J Hughes
Journal:  Mov Disord       Date:  1998-11       Impact factor: 10.338

9.  Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?

Authors:  Pablo Martínez-Martín; Julian Benito-León; Fernando Alonso; M José Catalán; Margarita Pondal; Aurelio Tobías; Ivana Zamarbide
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

10.  Fatigue in Parkinson's disease patients.

Authors:  Joseph H Friedman
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

View more
  26 in total

1.  Metastatic breast cancer patients' expectations and priorities for symptom improvement.

Authors:  Danielle B Tometich; Catherine E Mosher; Adam T Hirsh; Kevin L Rand; Shelley A Johns; Marianne S Matthias; Samantha D Outcalt; Bryan P Schneider; Lida Mina; Anna Maria V Storniolo; Erin V Newton; Kathy D Miller
Journal:  Support Care Cancer       Date:  2018-05-07       Impact factor: 3.603

2.  Conceptualizing and prioritizing clinical trial outcomes from the perspectives of people with Parkinson's disease versus health care professionals: a concept mapping study.

Authors:  Catharina Sjödahl Hammarlund; Maria H Nilsson; Markus Idvall; Scott R Rosas; Peter Hagell
Journal:  Qual Life Res       Date:  2014-01-04       Impact factor: 4.147

3.  The effect of Tai Chi exercise on gait initiation and gait performance in persons with Parkinson's disease.

Authors:  Shinichi Amano; Joe R Nocera; Srikant Vallabhajosula; Jorge L Juncos; Robert J Gregor; Dwight E Waddell; Steven L Wolf; Chris J Hass
Journal:  Parkinsonism Relat Disord       Date:  2013-07-05       Impact factor: 4.891

Review 4.  Integrating Patient Concerns into Parkinson's Disease Management.

Authors:  Shen-Yang Lim; Ai Huey Tan; Susan H Fox; Andrew H Evans; Soon Chai Low
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

5.  Social impact of peripheral nerve injuries.

Authors:  Danielle M Wojtkiewicz; James Saunders; Leahthan Domeshek; Christine B Novak; Vicki Kaskutas; Susan E Mackinnon
Journal:  Hand (N Y)       Date:  2015-06

6.  Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease.

Authors:  Matej Skorvanek; Iveta Nagyova; Jaroslav Rosenberger; Martina Krokavcova; Radka Ghorbani Saeedian; Johan W Groothoff; Zuzana Gdovinova; Jitse P van Dijk
Journal:  J Neurol       Date:  2013-01-09       Impact factor: 4.849

7.  Measuring outcomes in Parkinson's disease: a multi-perspective concept mapping study.

Authors:  Catharina Sjödahl Hammarlund; Maria H Nilsson; Peter Hagell
Journal:  Qual Life Res       Date:  2011-08-26       Impact factor: 4.147

8.  Views of women and clinicians on postpartum preparation and recovery.

Authors:  Anika Martin; Carol Horowitz; Amy Balbierz; Elizabeth A Howell
Journal:  Matern Child Health J       Date:  2014-04

Review 9.  Deep brain stimulation improves gait velocity in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Jaimie A Roper; Nyeonju Kang; Juliana Ben; James H Cauraugh; Michael S Okun; Chris J Hass
Journal:  J Neurol       Date:  2016-04-28       Impact factor: 4.849

10.  Psychometric properties of the Berg balance scale in idiopathic Parkinson' disease in the drug off-phase.

Authors:  Ghorban Taghizadeh; Pablo Martinez-Martin; Seyed-Mohammad Fereshtehnejad; Seyed Amirhasan Habibi; Negar Nikbakht; Naeeme Haji Alizadeh; Sheyda Salehi; Maryam Mehdizadeh
Journal:  Neurol Sci       Date:  2018-09-22       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.